Latest filing published 11 May 2026 for 환인제약.
Insider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
이원범: trading record in brief
This profile gathers the share dealings of 이원범 in 환인제약, where the filings describe the role as chief executive. The record holds 8 filings, for trades running from 19 July 2023 to 6 May 2026.
On the market, this insider has only ever bought: 1 purchase. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 11 May 2026: a transaction, in 환인제약. The last insider purchase was made public on 30 October 2025, 374 days ago. Filings reach the DART (FSS) feed a median of 7 days after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 이원범
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0KRXDART:20260511000215
- 1,860,000 sharesShareKRXDART:20251030000460Canonical exit: 28 Jan 2026 (T+90)
- ShareKRXDART:20231222000463
- ShareKRXDART:20231213000400
- ShareKRXDART:20231027000219
- ShareKRXDART:20230808000102
- ShareKRXDART:20230726000200
8 of 8 declarations